3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Leukemia
31
Leukemia, Promyelocytic, Acute
26
Multiple Myeloma
17
Leukemia, Myeloid, Acute
16
Neoplasms, Plasma Cell
12
Myelodysplastic Syndromes
12
Leukemia, Myelomonocytic, Chronic
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Anemia, Refractory, with Excess of Blasts
7
Lymphoma
6
Leukemia, Monocytic, Acute
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Blast Crisis
6
Neoplasms
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Follicular
5
Leukemia, Myelomonocytic, Acute
5
Leukemia, Megakaryoblastic, Acute
5
Leukemia, Erythroblastic, Acute
5
Burkitt Lymphoma
5
Recurrence
4
Myeloproliferative Disorders
4
Myelodysplastic-Myeloproliferative Diseases
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Central Nervous System Neoplasms
4
Interventions
pembrolizumab
23
Nivolumab
22
aldesleukin
21
Cyclophosphamide
20
Ipilimumab
17
Interleukin-2
17
fludarabine
15
fludarabine phosphate
14
cemiplimab
12
Radiotherapy
7
Fluorouracil
7
Dacarbazine
6
binimetinib
5
Vemurafenib
5
Temozolomide
5
Surgical Procedures, Operative
5
Sirolimus
5
Radiation
5
Biopsy
5
Aminolevulinic Acid
5
encorafenib
4
dabrafenib
4
Photochemotherapy
4
Educational Status
4
trametinib
3
sonidegib
3
montanide ISA 51
3
avelumab
3
Tacrolimus
3
Sodium Chloride
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Skin Neoplasms
×
Arsenic Trioxide
×
Clear all
NCT01791894
2018-06-08
ATO
Stanford University
Phase 1/2
Completed
5 enrolled
9 charts